Romelu Lukaku is set to rejoin Chelsea in a huge £ 97 million transfer. Lukaku left Chelsea in 2014 after 15 appearances there following his arrival at Stamford Bridge from Anderlecht in 2011. Chelsea have agreed to resign the striker from Inter Milan.
The paperwork is now with club lawyers and once that is formalised , Lukaku will undergo medical and sign a five year contract.
Former Chelsea legend Didier Drogba confirmed the news on his twitter. Tagging both Lukaku and Chelsea in a tweet featuring a photoshopped image of the striker in the new Chelsea kit, Drogba wrote: " He's coming home" followed by a string of blue heart emojis.
Drogba replied to his own tweet with a tick emoji as if to confirm the news, leaving Chelsea fans overjoyed.
Lukaku is set to undergo his Chelsea medical on Monday rather than Sunday as earlier stated ahead of a transfer to the Starmford Bridge , according to reports in Italy
Content created and supplied by: GreatJoel (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More